With these 3 growth stocks, I’m hoping to build generational wealth

Edward Sheldon believes these three growth stocks are capable of generating spectacular returns for his portfolio over the next few decades.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Happy parents playing with little kids riding in box

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investing in growth stocks can be a good way to create wealth for the long term. Just ask anyone who invested in Nvidia 10 years ago (its share price has increased roughly 245-fold since then).

Here, I’m going to highlight three growth stocks I’ve been buying recently in the hope of building wealth for future generations. I believe these shares have the potential to deliver substantial gains over the long term.

A platform for robo-taxis

First up we have Uber (NYSE:UBER). It’s a well-known rideshare and food delivery company.

I started buying this stock last year when it was trading near $40. And, so far, it’s done well for me, rising to around $70.

I think it’s just getting started though. Over the next few decades, I expect the stock to rise significantly as the company expands into new markets and its revenues and earnings climb.

One thing I’m particularly excited about here is robo-taxis. My view is that Uber will be the platform that many robo-taxi businesses operate on in the future.

It’s worth pointing out that there’s regulatory risk in the short term. Given its disruptive nature, this is a business regulators love to target.

Taking a long-term view however, I think it has bags of potential. It’s worth noting that the P/E ratio using next year’s earnings forecast is only about 30 – I think that’s good value.

Powering the online shopping revolution

Next, we have Shopify (NYSE: SHOP). It operates a large-scale online shopping platform that allows merchants to easily set up stores and start selling their products.

This stock’s been on a wild ride over the last few years. During the pandemic, it shot up as everyone got excited about online shopping. It then experienced a major crash as interest rates rose and growth stocks tanked.

The company’s continued to grow at a rapid pace the whole time however. Last year, for example, revenue climbed 26%. And the platform’s attracted some major brands. Businesses using Shopify today include the likes of GymShark, Red Bull and Nescafé.

Looking ahead, I’m expecting this stock to be volatile. If growth slows, the share price is likely to fall due to the company’s high valuation (the P/E ratio’s about 50).

As a long-term investor however, I’m comfortable with this volatility. In 10 years’ time, I reckon I’ll be looking at a winner.

The healthcare story of the decade

Finally, I’ve bought shares in pharma company Novo Nordisk (NYSE: NVO). It’s the maker of weight-loss drug Wegovy (and diabetes/weight-loss drug Ozempic).

This stock’s been a fabulous investment recently. Over the last five years, it’s climbed about 420% on the back of demand for its weight-loss and diabetes products.

I see plenty of potential for further growth over the next decade however. According to Morgan Stanley, the weight-loss drug market could be set to grow more than 15-fold by 2030.

Now, a risk here’s competition from rivals. Not only is Eli Lilly doing great things in the weight-loss drug space but lots of other pharma companies – including the UK’s AstraZeneca – are working on new products.

Novo Nordisk continues to spend billions on R&D however ($4.7bn in 2023). So I’m optimistic it can continue to be a market leader.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon has positions in Novo Nordisk, Nvidia, Shopify, and Uber Technologies. The Motley Fool UK has recommended AstraZeneca Plc, Novo Nordisk, Nvidia, Shopify, and Uber Technologies. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Person holding magnifying glass over important document, reading the small print
Investing Articles

Just released: our top 3 small-cap stocks to consider buying in October [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Investing Articles

How I’d use an empty Stocks and Shares ISA to aim for a £1,000 monthly passive income

Here's how using a Stocks and Shares ISA really could help those of us who plan to invest for an…

Read more »

Investing Articles

This FTSE stock is up 20% and set for its best day ever! Time to buy?

This Fool takes a look at the half-year results from Burberry (LON:BRBY) to see if the struggling FTSE stock might…

Read more »

Investing Articles

This latest FTSE 100 dip could be an unmissable opportunity to pick up cut-price stocks

The FTSE 100 has pulled back with the government’s policy choices creating some negative sentiment. But this gives us a…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

As the WH Smith share price falls 4% on annual results, is it still worth considering?

WH Smith took a hit after this morning’s results left shareholders unimpressed. With the share price down 4%, Mark Hartley…

Read more »

Investing Articles

The Aviva share price just jumped 4.5% but still yields 7.02%! Time to buy?

A positive set of results has put fresh life into the Aviva share price. Harvey Jones says it offers bags…

Read more »

Investing Articles

Can a €500m buyback kickstart the Vodafone share price?

The Vodafone share price has been a loser for investors in recent years, and the dividend has been cut. We…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Growth Shares

3 mistakes I now avoid when choosing which growth stocks to buy

Jon Smith runs through some of the lessons he's learnt the hard way over the years about what to look…

Read more »